论文信息 - Randomized Placebo‐Controlled and Controlled Non‐Inferiority Phase III Trials Comparing Trafermin, a Recombinant Human Fibroblast Growth Factor 2, and Enamel Matrix Derivative in Periodontal Regeneration in Intrabony Defects - 字舞流文

Randomized Placebo‐Controlled and Controlled Non‐Inferiority Phase III Trials Comparing Trafermin, a Recombinant Human Fibroblast Growth Factor 2, and Enamel Matrix Derivative in Periodontal Regeneration in Intrabony Defects

Y. Izumi | H. Shimauchi | R. Sakagami | S. Takashiba | M. Kawanami | E. Imai | Y. Ogata | Koichi Ito | S. Murakami | H. Yoshie | K. Gomi | T. Nagata | Y. Furuichi | M. Yokota | K. Yamazaki | M. Kitamura | Shuichi Sato | T. Sasano | Matsuo Yamamoto | H. Kurihara | T. Fujii | T. Noguchi | Y. Hara | T. Hamachi | K. Maeda | K. Noguchi | T. Nakagawa | M. Fukuda | K. Kunimatsu | Mari Mori | M. Ohmae | T. Furuuchi | T. Ogasawara | M. Watanuki | M. Akamatsu | Hayuru Koizumi